Health and Healthcare

Biogen : BIIB

All Biogen Articles

606 Articles

Chris Lange | Jul 25, 2019 at 8:40 AM EDT

Major Biotechs See Rising Tide in Short Interest

The July 15 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Jul 23, 2019 at 10:15 AM EDT

Why Biogen’s Q2 Was So Great

Biogen shares rose after itreleased better than expected second-quarter financial results before the markets opened on Tuesday.

Chris Lange | Jul 11, 2019 at 9:50 AM EDT

Short Sellers Run for Cover From Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The June 28 short interest data…

Jon C. Ogg | Jul 9, 2019 at 4:45 PM EDT

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

President Trump lost ground with his efforts to force drug companies to list drug prices on TV ads, with the…

Jon C. Ogg | Jun 28, 2019 at 9:03 AM EDT

Top Analyst Upgrades and Downgrades: Aerojet Rocketdyne, Apple, Baidu, Biogen, Chesapeake Energy, Chipotle, McDonald’s, Nike, Procter & Gamble, Walgreens and More

The top analyst upgrades, downgrades and initiations on Friday included Aerojet Rocketdyne, Apple, Baidu, Biogen, Chesapeake Energy, Chipotle Mexican Grill,…

Chris Lange | Jun 26, 2019 at 10:05 AM EDT

Big Biotechs Scare Off Short Sellers

The June 14 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Jun 12, 2019 at 8:40 AM EDT

Big Biotechs Have Short Sellers on the Run

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The May 31 short interest data…

Chris Lange | May 28, 2019 at 8:35 AM EDT

Major Biotechs See a Rising Tide in Short Interest

The May 15 short interest data have been compared with the previous report, and short interest in most of these…

Chris Lange | May 21, 2019 at 9:05 AM EDT

Tuesday’s Top Analyst Upgrades and Downgrades: Tesla, Uber, Amgen, Biogen, Gilead, Deckers, Vertex Pharma, KKR and More

24/7 Wall St. reviews dozens of analyst research reports each day of the week to find new ideas for investors…

Chris Lange | May 10, 2019 at 8:55 AM EDT

Short Sellers Back Off Major Biotechs

The April 30 short interest data have been compared with the previous report, and short interest in most of these…

Jon C. Ogg | May 7, 2019 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Alibaba, Anadarko, Beyond Meat, Boeing, Ctrip.com, GW Pharma, Roku, Texas Instruments, Veeco and More

The top analyst upgrades, downgrades and initiations seen on Tuesday included Alibaba, Anadarko Petroleum, Beyond Meat, Boeing, Ctrip.com, GW Pharmaceuticals,…

Chris Lange | Apr 26, 2019 at 9:40 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The April 15 short interest data have been compared with the previous report, and short interest moves in these selected…

Jon C. Ogg | Apr 24, 2019 at 12:55 PM EDT

Top Biotech Stocks and ETFs: A Sector in Trouble or a Huge Bargain

24/7 Wall St. has looked over some of the biotech sector's laggards, and we have also looked over the top…

Chris Lange | Apr 10, 2019 at 9:15 AM EDT

Big Biotechs Confound Short Sellers

The March 29 short interest data have been compared with the previous report, and short interest moves in these selected…

Chris Lange | Mar 27, 2019 at 8:30 AM EDT

Big Biotechs Scare Off Short Sellers

The March 15 short interest data have been compared with the previous report, and short interest in most of the…

1 … 8 9 10 11 12 … 41

Biogen : BIIB

All Biogen Articles

Major Biotechs See Rising Tide in Short Interest

Why Biogen’s Q2 Was So Great

Short Sellers Run for Cover From Major Biotechs

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

Top Analyst Upgrades and Downgrades: Aerojet Rocketdyne, Apple, Baidu, Biogen, Chesapeake Energy, Chipotle, McDonald’s, Nike, Procter & Gamble, Walgreens and More

Big Biotechs Scare Off Short Sellers

Big Biotechs Have Short Sellers on the Run

Major Biotechs See a Rising Tide in Short Interest

Tuesday’s Top Analyst Upgrades and Downgrades: Tesla, Uber, Amgen, Biogen, Gilead, Deckers, Vertex Pharma, KKR and More

Short Sellers Back Off Major Biotechs

Top Analyst Upgrades and Downgrades: Alibaba, Anadarko, Beyond Meat, Boeing, Ctrip.com, GW Pharma, Roku, Texas Instruments, Veeco and More

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Top Biotech Stocks and ETFs: A Sector in Trouble or a Huge Bargain

Big Biotechs Confound Short Sellers

Big Biotechs Scare Off Short Sellers

‘Traders Need to Be Really Careful Here’: Schwab on the Fed Decision and Powell’s Uncertain Future

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

This Dividend ETF Is up 30% in 6 Months With a 3.7% Dividend Yield

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Long-Term Care Could Cost This 68-Year-Old Couple $380,000 and Their $2.1 Million Portfolio Is Not Structured for It

‘Traders Need to Be Really Careful Here’: Schwab on the Fed Decision and Powell’s Uncertain Future

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Biogen : BIIB

All Biogen Articles

Major Biotechs See Rising Tide in Short Interest

Why Biogen’s Q2 Was So Great

Short Sellers Run for Cover From Major Biotechs

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

Top Analyst Upgrades and Downgrades: Aerojet Rocketdyne, Apple, Baidu, Biogen, Chesapeake Energy, Chipotle, McDonald’s, Nike, Procter & Gamble, Walgreens and More

Big Biotechs Scare Off Short Sellers

Big Biotechs Have Short Sellers on the Run

Major Biotechs See a Rising Tide in Short Interest

Tuesday’s Top Analyst Upgrades and Downgrades: Tesla, Uber, Amgen, Biogen, Gilead, Deckers, Vertex Pharma, KKR and More

Short Sellers Back Off Major Biotechs

Top Analyst Upgrades and Downgrades: Alibaba, Anadarko, Beyond Meat, Boeing, Ctrip.com, GW Pharma, Roku, Texas Instruments, Veeco and More

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Top Biotech Stocks and ETFs: A Sector in Trouble or a Huge Bargain

Big Biotechs Confound Short Sellers

Big Biotechs Scare Off Short Sellers

‘Traders Need to Be Really Careful Here’: Schwab on the Fed Decision and Powell’s Uncertain Future

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

This Dividend ETF Is up 30% in 6 Months With a 3.7% Dividend Yield

Featured Reads

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Long-Term Care Could Cost This 68-Year-Old Couple $380,000 and Their $2.1 Million Portfolio Is Not Structured for It